Heartland lawmakers' response to Mueller Report is low key

By  | 

OMAHA, Neb. (WOWT) -- The response from heartland lawmakers to Thursday's release of the Mueller report has been reserved, and rather sparse.

Sen. Joni Ernst, R-Iowa

Iowa Sen. Joni Ernst, a member of the Senate Judiciary Committee, released the following statement on the release of the Special Counsel’s report:

“I’ve long called for as much of the Mueller report that can be made public under the law to be made available to the ones who paid millions for it—the American people. I look forward to reviewing the report.”

Rep. Jeff Fortenberry, R-Neb.

“This morning, U.S. Attorney General William Barr fulfilled his promise to release the full Mueller Report. While portions of the public version of the special counsel’s report had to be redacted to protect intelligence sources and methods, as well as grand jury testimony, Members of Congress from both parties will now be able to review most of the un-redacted report,” Fortenberry said. “I am grateful to the Attorney General for his commitment to transparency while protecting the integrity of the investigative process,” Fortenberry added.

“The Mueller report should be thoroughly evaluated, but not used to create a permanent political crisis,” Fortenberry stated.

Congressman Jeff Fortenberry is a member of the House Appropriations Subcommittee on State and Foreign Operations.

Sen. Chuck Grassley, R-Iowa

Rep. Don Bacon, R-Neb.

“My position was clear when I voted with my 419 colleagues in the House urging the release of the Mueller report. Attorney General Barr has released it within the bounds of the law, just as he said he would. That the report clearly says there was no evidence of criminal collusion with Russia should bring peace of mind to our nation.

“Along with the rest of the nation, I will be reviewing the full report. Congress must start working together to build consensus on how to best solve the most pressing challenges facing our country, such as immigration policy, border security and prescription drugs.”